A detailed history of Mountain Pacific Investment Advisers Inc transactions in Abbott Laboratories stock. As of the latest transaction made, Mountain Pacific Investment Advisers Inc holds 26,625 shares of ABT stock, worth $3.12 Million. This represents 0.21% of its overall portfolio holdings.

Number of Shares
26,625
Previous 25,625 3.9%
Holding current value
$3.12 Million
Previous $2.66 Million 14.01%
% of portfolio
0.21%
Previous 0.2%

Shares

23 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2024

Oct 08, 2024

BUY
$100.07 - $118.13 $100,070 - $118,130
1,000 Added 3.9%
26,625 $3.04 Million
Q2 2024

Jul 10, 2024

SELL
$100.73 - $112.44 $357,591 - $399,162
-3,550 Reduced 12.17%
25,625 $2.66 Million
Q1 2024

Apr 11, 2024

SELL
$109.52 - $120.96 $10,952 - $12,096
-100 Reduced 0.34%
29,175 $3.32 Million
Q4 2023

Feb 02, 2024

BUY
$90.19 - $110.4 $111,384 - $136,344
1,235 Added 4.4%
29,275 $3.22 Million
Q3 2023

Oct 20, 2023

SELL
$95.53 - $114.62 $71,647 - $85,965
-750 Reduced 2.61%
28,040 $2.72 Million
Q2 2023

Jul 26, 2023

SELL
$100.78 - $112.29 $30,133 - $33,574
-299 Reduced 1.03%
28,790 $3.14 Million
Q1 2023

May 23, 2023

SELL
$96.86 - $114.01 $132,698 - $156,193
-1,370 Reduced 4.5%
29,089 $2.95 Million
Q4 2022

Jan 20, 2023

SELL
$95.06 - $111.52 $3,897 - $4,572
-41 Reduced 0.13%
30,459 $0
Q3 2022

Oct 13, 2022

SELL
$96.76 - $112.03 $12,965 - $15,012
-134 Reduced 0.44%
30,500 $2.95 Million
Q2 2022

Jul 21, 2022

SELL
$102.07 - $123.37 $81,656 - $98,696
-800 Reduced 2.55%
30,634 $3.33 Million
Q4 2021

Jan 19, 2022

SELL
$115.53 - $141.46 $184,848 - $226,336
-1,600 Reduced 4.84%
31,434 $4.42 Million
Q3 2021

Oct 25, 2021

BUY
$116.66 - $129.06 $583 - $645
5 Added 0.02%
33,034 $3.9 Million
Q2 2021

Aug 16, 2021

SELL
$105.79 - $124.53 $21,158 - $24,906
-200 Reduced 0.6%
33,029 $3.83 Million
Q1 2021

Apr 14, 2021

SELL
$108.84 - $128.23 $54,420 - $64,114
-500 Reduced 1.48%
33,229 $3.98 Million
Q4 2020

Jan 21, 2021

SELL
$105.0 - $114.42 $21,840 - $23,799
-208 Reduced 0.61%
33,729 $3.69 Million
Q3 2020

Oct 13, 2020

BUY
$91.64 - $111.29 $61,307 - $74,453
669 Added 2.01%
33,937 $3.69 Million
Q1 2020

Apr 08, 2020

SELL
$62.82 - $91.86 $37,692 - $55,116
-600 Reduced 1.77%
33,268 $2.63 Million
Q3 2019

Oct 15, 2019

BUY
$81.84 - $88.74 $16,368 - $17,748
200 Added 0.59%
33,868 $2.83 Million
Q2 2019

Jul 23, 2019

BUY
$72.88 - $85.0 $30,390 - $35,445
417 Added 1.25%
33,668 $2.83 Million
Q1 2019

May 07, 2019

SELL
$66.22 - $80.06 $33,242 - $40,190
-502 Reduced 1.49%
33,251 $2.66 Million
Q4 2018

Jan 25, 2019

BUY
$65.56 - $74.27 $3,409 - $3,862
52 Added 0.15%
33,753 $2.44 Million
Q4 2017

Jan 23, 2018

SELL
$53.68 - $57.47 $8,052 - $8,620
-150 Reduced 0.44%
33,701 $1.92 Million
Q3 2017

Oct 20, 2017

BUY
$48.06 - $53.64 $1.63 Million - $1.82 Million
33,851
33,851 $1.81 Million

Others Institutions Holding ABT

About ABBOTT LABORATORIES


  • Ticker ABT
  • Exchange NYSE
  • Sector Healthcare
  • Industry Medical Devices
  • Shares Outstandng 1,751,219,968
  • Market Cap $205B
  • Description
  • Abbott Laboratories, together with its subsidiaries, discovers, develops, manufactures, and sells health care products worldwide. It operates in four segments: Established Pharmaceutical Products, Diagnostic Products, Nutritional Products, and Medical Devices. The Established Pharmaceutical Products segment provides generic pharmaceuticals for t...
More about ABT
Track This Portfolio

Track Mountain Pacific Investment Advisers Inc Portfolio

Follow Mountain Pacific Investment Advisers Inc and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Mountain Pacific Investment Advisers Inc, based on Form 13F filings with the SEC.

News

Stay updated on Mountain Pacific Investment Advisers Inc with notifications on news.